Octreotide for treating chylothorax after cardiac surgery

Chylothorax is a rare but serious complication of cardiac surgery, with a poor prognosis unless treated properly. We report the case of 66-year-old woman who developed chylothorax after coronary artery bypass grafting. The chylothorax was successfully treated in 8 days by means of subcutaneous octre...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Texas Heart Institute journal 2005, Vol.32 (3), p.437-439
Hauptverfasser:	Kilic, Dalokay, Sahin, Ekber, Gulcan, Oner, Bolat, Bulent, Turkoz, Riza, Hatipoglu, Ahmet
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Agents, Hormonal - therapeutic use Case Report Chylothorax - drug therapy Chylothorax - etiology Chylothorax - surgery Coronary Artery Bypass - adverse effects Coronary Disease - surgery Drainage Female Follow-Up Studies Humans Octreotide - therapeutic use Postoperative Complications
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Chylothorax is a rare but serious complication of cardiac surgery, with a poor prognosis unless treated properly. We report the case of 66-year-old woman who developed chylothorax after coronary artery bypass grafting. The chylothorax was successfully treated in 8 days by means of subcutaneous octreotide administration and a diet that contained medium-chain triglycerides. Octreotide, a long-acting somatostatin analog, is an effective and safe agent for the treatment of postoperative chylothorax and may reduce the need for reoperation.
ISSN:	0730-2347